Vivian Wan

1 INTRODUCTION Up to half of patients who undergo primary radiation therapy (RT) for prostate cancer (CaP) experience biochemical recurrence (BCR) within 10 years of definitive therapy.1 Biopsy studies also show that 15%–20% of patients treated with primary RT have residual disease, suggesting true local failure.2 Recurrence or local failure after RT is associated with worse overall survival, CaP-specific survival and distant metastasis-free survival.3 In contrast to recurrence after radical...

Les Britanniques avaient quitté le dispositif fin 2020 avec la sortie de l’UE, au grand dam des étudiants. La Commission européenne salue ce mercredi 17 décembre un «grand pas en avant». L'université King's College à Cambridge, le 21 octobre 2024. (Vivian Wan/Bloomberg.

Highlights • It fortells that the majority of the study populations still had lower proportions that were immune. • It discusses potential factors affecting the herd immunity equation and how realistic the herd immunity is.